Differential Effects of Tat Proteins Derived from HIV-1 Subtypes B and Recombinant CRF02_AG on Human Brain Microvascular Endothelial Cells: Implications for Blood–Brain Barrier Dysfunction
Open Access
- 26 March 2014
- journal article
- clinical trial
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 34 (6) , 1047-1059
Abstract
HIV-1 genetic differences influence viral replication and progression to AIDS. HIV-1 circulating recombinant form (CRF)02_AG is the predominant viral subtype infecting humans in West and Central Africa, but its effects on HIV neuropathogenesis are not known. In the present study, we investigated the effects of Tat proteins from HIV-1 subtype B (Tat.B) and HIV-1 CRF02_AG (Tat.AG) on primary human brain microvascular endothelial cells (HBMEC), the major component of the blood–brain barrier (BBB). Using Affymetrix GeneChip Human Gene 1.0.ST arrays, we showed that Tat.AG had minimal effects while Tat.B induced transcriptional upregulation of 90 genes in HBMEC, including proinflammatory chemokines, complement components C3, C7, and complement factor B, matrix metalloproteinases (MMP)-3, MMP-10, and MMP-12. These results were confirmed by real-time PCR. Compared with Tat.AG, Tat.B significantly increased MMP-3, MMP-10, and MMP-12 activities in HBMEC, and the MMPs tissue inhibitor of metalloproteinase-2 blocked Tat-induced increase in MMPs activity. Western blot analyses also showed that Tat increased the expression of C3 and its cleaved fragment C3b in HBMEC. These data suggest that genetic differences between HIV-1 subtypes B and CRF02_AG influence the effects of Tat proteins from these two clades on HBMEC, including molecular and cellular functions, and canonical pathways, which would affect BBB dysfunction and viral neuropathogenesis.Keywords
This publication has 38 references indexed in Scilit:
- Cross‐talk between STAT1 and PI3K/AKT signaling in HIV‐1‐induced blood–brain barrier dysfunction: Role of CCR5 and implications for viral neuropathogenesisJournal of Neuroscience Research, 2010
- MMP-12 induces IL-8/CXCL8 secretion through EGFR and ERK1/2 activation in epithelial cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular diseaseBiochemical Pharmacology, 2008
- Neurotoxicity of HIV-1 Tat protein: Involvement of D1 dopamine receptor☆NeuroToxicology, 2007
- Updated research nosology for HIV-associated neurocognitive disordersNeurology, 2007
- Human Immunodeficiency Virus Type 1 Subtype C Tat Fails To Induce Intracellular Calcium Flux and Induces Reduced Tumor Necrosis Factor Production from MonocytesJournal of Virology, 2007
- HIV-tat induces formation of an LRP–PSD-95– NMDAR–nNOS complex that promotes apoptosis in neurons and astrocytesProceedings of the National Academy of Sciences, 2007
- Endothelial Extracellular MatrixCirculation Research, 2005
- HIV-1 Tat increases the adhesion of monocytes and T-cells to the endothelium in vitro and in vivo: implications for AIDS-associated vasculopathyVirus Research, 2004
- Tat Protein of Human Immunodeficiency Virus Type 1 Subtype C Strains Is a Defective ChemokineJournal of Virology, 2004